Our preliminary data show that a combination of a natural compound (homoharringtonine) and an AKT1 inhibitor (A674563) that is important for N-Myc protein stability significantly reduces the expression of INSM1, N-Myc, and NB tumor cell growth (unpublished results). The gene discussed is MYCN; the disease is neuroblastoma.